Vultaggio Vincent bought ZNTL
February 3, 2025 · Form 4 insider transaction
Vultaggio Vincent bought 35,633 shares of Zentalis Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
35,633
Price
$0.00
Total value
N/A
InsiderVultaggio Vincent
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2025
Filing dateFebruary 5, 2025
Shares owned after35,633
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.